August 22, 2017
Quantum Pharma net debt reduced
Quantum Pharma posted financial results for the first half 2017 with revenue increased by 13% to £36.2M mostly from growth from the Niche Pharmaceuticals division.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Quantum Pharma
January 24, 2017
Quantum Pharma grantes options to its CFO
Quantum Pharma, has granted options over 1,100,000 Ordinary Shares of 10 pence each (‘Ordinary Shares’) with an exercise price of 30 pence, to Gerard Murray, Chief Financial Officer.
October 20, 2016
Quantum Pharma plans raising £15M by placing shares
The company on Thursday said the Placing Shares are being offered by an accelerated bookbuild. Zeus Capital and N+1 Singer will be acting as joint bookrunners in connection with the Bookbuild, Quantum Pharma has said.
October 19, 2016
Quantum Pharma names new CEO and makes other board changes
Quantum Pharma names new CEO and makes other board changes
@qp_group
November 5, 2015
Quantum Pharma’s Colonis launches medical devices for side effects of cancer treatment
Colonis, part of Quantum Pharma’s newly formed Niche Pharmaceuticals division, has launched its in-licensed range of patented medical devices to treat…
October 14, 2015
Quantum Pharma:Licensing Agreement with Futura Medical
Quantum Pharma Plc has announced that it had signed an exclusive agreement with Futura Medical plc the healthcare company which is focused on advanced transdermal technology, to manufacture and make available MED2002, Futura’s novel treatment for erectile dysfunction, as an unlicensed medicine (special) in the UK (the “Agreement”).
September 21, 2015
Quantum Pharma wins Biodose Services contract with Yorkshire and Humber NHS
Quantum Pharma a service-led niche pharmaceutical manufacturer, developer and supplier to the health and care sectors has anounced first large-scale NHS homecare contract…
You must be logged in to post a comment.